Xtrackers MSCI World Health Care UCITS ETF 1c

ISIN IE00BM67HK77 · XDWH EU World

The Xtrackers MSCI World Health Care UCITS ETF 1c is an exchange-traded index fund (ETF) from Xtrackers that tracks the MSCI World Health Care index physically. Income is distributed to investors; it trades as a Europe-domiciled UCITS fund. The fund spreads across 111 individual holdings – the largest currently Eli Lilly at 12.12%. The full composition plus the sector and country breakdown are shown below; it is one of 104 ETFs we cover.

The ten largest holdings make up 48.9% of the fund, out of 111 in total. The largest sector is Pharmaceuticals at 46.6% (as of Nov 2, 2026).

Alysly Data Analysis: XDWH

Data Points

The map shows how XDWH connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.

View the full data network

The 100 Largest Holdings

of 111 in total · as of Nov 2, 2026

Top holdings
#StockTickerWeight
1Eli LillyLLY12.12%
2Johnson & JohnsonJNJ7.30%
3AbbVie Inc.ABBV5.67%
4UnitedHealth Group IncorporatedUNH4.11%
5Merck & Co. Inc.MRK3.98%
6Roche Holding LtdRO3.92%
7Novartis AGNOVN3.23%
8Astrazeneca plcAZN2.91%
9Thermo Fisher Scientific Inc.TMO2.91%
10Amgen Inc.AMGN2.74%
11Gilead Sciences Inc.GILD2.27%
12Abbott LaboratoriesABT2.01%
13Pfizer Inc.PFE1.88%
14Intuitive Surgical Inc.ISRG1.75%
15Danaher CorporationDHR1.66%
16Vertex Pharmaceuticals IncorporatedVRTX1.51%
17Bristol-Myers Squibb CompanyBMY1.38%
18Novo Nordisk A/S1.38%
19Medtronic PlcMDT1.37%
20CVS Health CorporationCVS1.27%
21McKesson CorporationMCK1.27%
22Stryker CorporationSYK1.19%
23GlaxosmithklineGSK1.08%
24Sanofi SASAN1.02%
25Elevance Health Inc.ELV1.01%
26Regeneron Pharmaceuticals Inc.REGN0.93%
27Cigna GroupCI0.87%
28HCA Healthcare IncHCA0.82%
29CSL LimitedCSL0.73%
30Takeda Pharmaceutical Co. Ltd.45020.72%
31Boston Scientific CorporationBSX0.70%
32Cencora Inc.COR0.67%
33Natera Inc.NTRA0.65%
34Cardinal Health Inc.CAH0.65%
35Essilorluxottica SAEL0.64%
36argenx SEARGX0.62%
37Hoya Corp.77410.62%
38Becton Dickinson and Co0.60%
39Lonza Group AGLONN0.60%
40Edwards Lifesciences CorporationEW0.60%
41Bayer AGBAYN0.58%
42Agilent Technologies Inc.A0.56%
43Humana Inc.HUM0.55%
44Teva Pharmaceutical Industries LimitedTEVA0.54%
45Waters CorporationWAT0.52%
46IQVIA Holdings IncIQV0.51%
47IDEXX Laboratories Inc.IDXX0.50%
48Veeva Systems Inc. Class AVEEV0.50%
49Illumina Inc.ILMN0.47%
50Galderma Group N AGGALD0.47%
51Sandoz Group LtdSDZ0.46%
52UCB S.A.UCB0.42%
53Haleon plcHLN0.41%
54Biogen Inc.BIIB0.41%
55ResMed Inc.RMD0.40%
56Mettler-Toledo International Inc0.38%
57GE Healthcare Technologies Inc.GEHC0.38%
58Alcon AGALC0.38%
59Centene CorporationCNC0.37%
60Genmab A/SGMAB0.37%
61Zoetis Inc. Class AZTS0.36%
62Otsuka Corp.47680.36%
63Revolution Medicines Inc.RVMD0.36%
64DexCom Inc.DXCM0.34%
65Labcorp Holdings Inc.LH0.33%
66West Pharmaceutical Services Inc.WST0.32%
67Chugai Pharmaceutical Co. Ltd.45190.31%
68Quest Diagnostics IncorporatedDGX0.31%
69Daiichi Sankyo Company Limited45680.31%
70Astellas Pharma Inc.45030.30%
71Royalty Pharma Plc Class ARPRX0.30%
72Insmed IncorporatedINSM0.26%
73Alnylam Pharmaceuticals IncALNY0.26%
74STERIS plcSTE0.25%
75United Therapeutics CorporationUTHR0.25%
76Fresenius SE & Co. KGaAFRE0.24%
77Merck KGaAMRK0.24%
78Koninklijke Philips N.V.PHIA0.23%
79Terumo Corporation45430.22%
80Incyte CorporationINCY0.22%
81Roivant Sciences Ltd.ROIV0.22%
82Zimmer Biomet Holdings Inc.ZBH0.21%
83Sonova Holding AGSOON0.18%
84Siemens Healthineers AGSHL0.18%
85Fisher & Paykel Healthcare Corporation LimitedFPH0.17%
86Shionogi & Co. Ltd.45070.16%
87Neurocrine Biosciences Inc.NBIX0.15%
88Straumann Holding AGSTMN0.14%
89Orion Oyj Class BORNBV0.13%
90Medline Inc. Class AMDLN0.13%
91Olympus Corp.77330.13%
92Cooper Companies Inc0.13%
93Smith and Nephew plcSN.0.13%
94Eurofins Scientific SEERF0.12%
95Qiagen N.V.QIA0.11%
96Sigma Healthcare LtdSIG0.11%
97Coloplast A/S Class BCOLO B0.10%
98Swedish Orphan Biovitrum ABSOBI0.10%
99Fresenius Medical Care AGFME0.09%
100Eisai Co. Ltd.45230.09%

Top Sectors

Pharmaceuticals46.6%
Biotechnology17.8%
Health Care Equipment11.8%
Life Sciences Tools & Services8.4%
Managed Health Care6.1%
Health Care Services2.9%
Health Care Distributors2.7%
Health Care Supplies2.0%
Health Care Facilities1.1%
Health Care Technology0.6%

Geographic Breakdown

United States72.8%
Switzerland9.8%
United Kingdom4.3%
Japan3.3%
France1.9%
Denmark1.9%
Ireland1.6%
Germany1.4%
Netherlands1.0%
Israel0.5%
Belgium0.5%
Australia0.2%

Holdings lists from our database since Sep 30, 2026, 3 reporting dates.

Data note 1

Changes in Holdings

This compares the holdings list of Sep 30, 2026 with that of Nov 2, 2026: 9 names were added and 11 dropped out. Weights also shift without any buying or selling, because the prices of the holdings move differently.

Added

  • Eli Lilly and Co · 12.12%
  • Novo Nordisk A/S · 1.38%
  • Becton Dickinson and Co · 0.60%
  • Veeva Systems Inc · 0.50%
  • Mettler-Toledo International Inc · 0.38%

Removed

  • Eli Lilly · 11.15%
  • Roche PS Par AG · 3.53%
  • Novo Nordisk Class B · 1.45%
  • Becton Dickinson · 0.59%
  • Veeva Systems Class A · 0.48%

Weight Up

  • Roche Holding AG · 3.92% (+3.77 pp)
  • AbbVie Inc · 5.67% (+0.13 pp)
  • Genmab · 0.37% (+0.13 pp)
  • Amgen Inc · 2.74% (+0.09 pp)
  • Novartis AG · 3.23% (+0.09 pp)

Weight Down

  • Johnson & Johnson · 7.30% (-0.39 pp)
  • Merck & Co Inc · 3.98% (-0.33 pp)
  • Bristol-Myers Squibb Co · 1.38% (-0.15 pp)
  • Alnylam Pharmaceuticals Inc · 0.26% (-0.14 pp)
  • Glaxosmithkline · 1.08% (-0.09 pp)

Data note 2

Compared With Other Funds

How much this fund overlaps with others — the figure is the share of capital financing the same companies in both.

Data note 3

Data and Charts: XDWH

ListingEurope (UCITS)
Cost (TER)–
IndexMSCI World Health Care
Replication
Distribution
Holdings111
effective27

Effective means the number of equally weighted holdings that would produce the same spread as this fund's 111 counted positions.

Data note 4

Key Facts

Key facts
Distribution
Product structure

Data note 5

NAV History

The chart shows net asset value per share and is set to the current year by default. The NAV is up 15.6% year to date and up 23.9% over twelve months. The last recorded close on October 30, 2026, was at 100% of the 52-week range.

Net asset value per share in USD, set once per trading day. It is not an exchange price. Distributions are not added back, so for distributing funds the value drops by the amount paid out on the distribution date.

Net asset values from our database since Nov 22, 2010, 4,018 daily values.

Data note 6

Performance

Calculated from the fund's NAV history.

Performance figures
Trailing (1Y)+23.9%Year to date+15.6%
Calendar year 2011+9.0%
Calendar year 2012+17.1%
Calendar year 2013+35.9%
Calendar year 2014+17.7%
Calendar year 2015+6.2%
Calendar year 2016-5.3%
Calendar year 2017+20.1%
Calendar year 2018+1.1%
Calendar year 2019+24.4%
Calendar year 2020+13.3%
Calendar year 2021+19.7%
Calendar year 2022-5.4%
Calendar year 2023+3.7%
Calendar year 2024+1.1%
Calendar year 2025+14.8%

Data note 7

Fundamental Analysis: XDWH

Tax (Germany)

Equity ETF: 30% partial exemption (Teilfreistellung). Distributing → Vorabpauschale barely relevant. Details.

Alternative ETFs on the Same Index

Updated